According to the researchers, nanobodies are typically easier to produce cost-effectively on a mass scale
West Java Governor Ridwan Kamil flexes his arm after receving the COVID-19 vaccine as part of a clinical trial in Bandung. Pic/AFP
To fight against the Coronavirus, scientists have identified a small neutralising antibody, a so-called nanobody, that has the capacity to block SARS-CoV-2 from entering human cells.
ADVERTISEMENT
The study, published in the journal Nature Communications, suggests that this nanobody has the potential to be developed as an antiviral treatment against COVID-19.
The search for effective nanobodies, which are fragments of antibodies that occur naturally in camelids, began in February when an alpaca was injected with the new Coronavirus' spike protein, which is used to enter our cells.
After 60 days, blood samples from the alpaca showed a strong immune response against the spike protein. "We are now embarking on preclinical animal studies to investigate its therapeutic potential," they noted.
Czech sees 700 cases for 1st time
Prague: The number of people infected with the Coronavirus in the Czech Republic has surpassed 700 for the first time. The Health Ministry says the day-to-day increase reached a record of 798 new confirmed cases on Friday. The announcement comes after the country registered over 600 cases the previous two days.
Keep scrolling to read more news
Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.
Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news
This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever
Subscribe today by clicking the link and stay updated with the latest news!" Click here!
